Andrew counsels and defends clients in a wide range of high-stakes antitrust and complex commercial litigation matters. Clients count on Andrew to bring top-flight advocacy and strategy to all phases of trial and appellate litigation. He brings a seasoned perspective to his representation of pharmaceutical companies in Hatch-Waxman cases at the intersection of U.S. patent and antitrust law. Andrew Hatchett represents clients in a wide range of complex commercial litigation with an emphasis on antitrust cases in the pharmaceutical and life sciences sectors. Andrew has represented clients in cases alleging horizontal and vertical conspiracies, unilateral monopolistic conduct, and a variety of other traditional and novel antitrust theories. Andrew also has an active appellate practice, having represented clients in appeals before the U.S. Supreme Court, the First, Second, Third, Sixth, Eighth, Ninth, and Eleventh Circuits, and various state appellate courts. Andrew is recognized by The Best Lawyers of America© “Ones to Watch” for Commercial Litigation. Before joining Alston & Bird, Andrew served as a law clerk to the Hon. D. Brooks Smith of the U.S. Court of Appeals for the Third Circuit and the Hon. L. Scott Coogler of the U.S. District Court for the Northern District of Alabama. Andrew is active in the leadership of the American Bar Association’s (ABA) Section of Antitrust Law. He currently serves as vice chair of the Health Care and Pharmaceuticals Committee. In law school, Andrew received the Dean M. Leigh Harrison Award, the law school’s highest academic honor, and was inducted into both the Order of the Coif and the Order of the Barristers.